| IMMUNOCORE HLDGS ADS/1 |
| USA |
| Gesundheit |
| US45258D1054 / A2QNWU |
| 6YG (Frankfurt) / IMCR (NASDAQ) |
| FRA:6YG, ETR:6YG, 6YG:GR, NASDAQ:IMCR |
| - |
| https://www.immunocore.co.. |
|
Immunocore Holdings plc is a leading biotechnology company that specializes in the development of T cell receptor (TCR) therapies, holding a significant promise in treating various types of cancer, autoimmune disorders, and infectious diseases. As an..
>Volltext.. |
| 1283.71 Mio. EUR |
| 914.11 Mio. EUR |
| 346.54 Mio. EUR |
| -36.49 Mio. EUR |
| -30.76 Mio. EUR |
| -0.61 EUR |
| 377.57 Mio. EUR |
| 404.39 Mio. EUR |
| -9.28 Mio. EUR |
| 3.5 |
| 29.17% |
| 29.93% |
| - |
| - |
| - |
| - |
| IMMUNOCORE |
| 01.04.26 |
|
||||
|